Boulevard Bio

Sarasota, Fla., August 11, 2026 Belenos Biosciences announced positive topline results from a Phase 2 clinical trial of BEL512...

NEW YORK, New York, August 12, 2026 Boulevard Bio has emerged from stealth with approximately $65 million in financing...